Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
197.66
+1.27 (0.65%)
May 29, 2026, 12:05 PM EDT - Market open
Biogen Stock Forecast
Stock Price Forecast
According to 36 analysts polled by S&P Global, Biogen stock has a consensus rating of "Buy" and an average price target of $219.44. The average 1-year stock price forecast is 11.02% higher than the current stock price, while the lowest is $150 (-24.11%) and the highest is $300 (+51.78%).
Price Target: $219.44 (+11.02%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Biogen stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 14 | 14 | 14 | 17 | 18 |
| Buy | 2 | 2 | 1 | 1 | 2 | 2 |
| Hold | 18 | 18 | 20 | 20 | 16 | 15 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 35 | 35 | 36 | 36 | 36 | 36 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $222 → $227 | Buy | Maintains | $222 → $227 | +14.84% | May 27, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 22, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $250 | Buy | Maintains | $250 | +26.48% | May 22, 2026 |
| Wedbush | Wedbush | Hold Maintains $196 | Hold | Maintains | $196 | -0.84% | May 18, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $238 → $250 | Buy | Maintains | $238 → $250 | +26.48% | May 15, 2026 |
Financial Forecast
Revenue This Year
10.13B
from 9.89B
Increased by 2.37%
Revenue Next Year
10.29B
from 10.13B
Increased by 1.66%
EPS This Year
14.90
from 8.79
Increased by 69.51%
EPS Next Year
16.61
from 14.90
Increased by 11.46%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 10.9B | 11.7B | ||||||
| Avg | 10.1B | 10.3B | ||||||
| Low | 9.3B | 8.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 9.9% | 15.6% | ||||||
| Avg | 2.4% | 1.7% | ||||||
| Low | -5.9% | -11.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 16.70 | 20.32 | ||||||
| Avg | 14.90 | 16.61 | ||||||
| Low | 12.79 | 12.64 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 89.9% | 36.4% | ||||||
| Avg | 69.5% | 11.5% | ||||||
| Low | 45.5% | -15.2% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.